02 BOOK OF ABSTRACTS .indd

11.50 – 12.15 Mackay Andrew R., University of L’Aquila, L’Aquila:
TrkAIII: A tumor promoting switch of potential importance in
neuroblastoma and glioblastoma mutliforme
12.15 – 12.40 Durán Alonso María Beatriz , National Institute of Biology,
Ljubljana:
Antiprotease therapy in cancer: hot or not?
12.40 – 12.55 Amberger-Murphy Verena, Dublin City
University, Dublin:
A three-dimensional in vitro model to study invasion
13.00 – 14.30 Lunch
14.30 – 16.30 Section 5: Continued
Chairs: Komel Radovan & Bjerkvig Rolf
14.30 – 14.55 Komel Radovan, University of Ljubljana, Ljubljana:
Functional genomics and systems biology for studying
oncogenesis
14.55 – 15.20 Bjerkvig Rolf, University of Bergen, Bergen:
Angiogenesis independent growth mediated by glioma stem
cells
15.20 – 15.45 Moin Kamiar, Wayne State University School of Medicine,
Detroit:
Tumor proteolysis: a multidimensional approach
15.45 – 16.10 Levi~ar Nata{a, Imperial College London, London:
Stem cell therapy for liver insufficiency
16.10 – 16.25 Strojnik Tadej, Maribor Teaching
Hospital, Maribor:
Experimental model and immunohistochemical analyses of
U87 human glioblastoma cells xenografts in the
immunosuppressed rat brains
16.25 – 16.40 ^erne Darko, University of Primorska, Izola:
Increased plasma DNA concentration in patients with lung
cancer
16.45 – 17.30 Break
17.30 – 18.30 Closing lecture
Chair: Lah Turn{ek Tamara
Platika Doros, The Pittsburgh Life Sciences Greenhouse,
Pittsburgh:
Leveraging a flat world: novel models for effective
translational research, product generation and
commercialization in oncology.
18.30 – 19.00 Closing of the meeting
19.00 – 20.15 Break
20.15 Farewell dinner
9